A detailed history of Ifp Advisors, Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 118 shares of ADMA stock, worth $2,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118
Holding current value
$2,000
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$15.62 - $22.62 $1,843 - $2,669
118 New
118 $2,000
Q3 2023

Oct 12, 2023

BUY
$3.47 - $4.61 $3,990 - $5,301
1,150 New
1,150 $4,000
Q3 2021

Oct 06, 2021

SELL
$1.13 - $1.65 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$1.51 - $2.07 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$1.67 - $2.95 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$1.8 - $2.56 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$2.04 - $3.74 $0 - $0
0 New
0 $0

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.33B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.